Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer

about

Regulatory and Exhausted T Cell Responses to AAV Capsid.The Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road

P2860

Q40282843-07E0D755-BAB9-467D-8E29-7D9FB512FEAA Q58750585-40E33FEC-F293-4013-A6FB-8B5389BF5596

P2860

Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer

Item

http://www.wikidata.org/entity/Q35949356

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Reprogramming Immune Response ...... rs for Immunotherapy of Cancer

@ast

Reprogramming Immune Response ...... rs for Immunotherapy of Cancer

@en

type

Item

label

Reprogramming Immune Response ...... rs for Immunotherapy of Cancer

@ast

Reprogramming Immune Response ...... rs for Immunotherapy of Cancer

@en

prefLabel

Reprogramming Immune Response ...... rs for Immunotherapy of Cancer

@ast

Reprogramming Immune Response ...... rs for Immunotherapy of Cancer

@en

P1476

Reprogramming Immune Response ...... rs for Immunotherapy of Cancer

@en

P2093

Kellee Britt

http://www.w3.org/2001/XMLSchema#string

Munjal Pandya

http://www.w3.org/2001/XMLSchema#string

P2860

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Dendritic cells and the control of immunity

Broad protection against influenza infection by vectored immunoprophylaxis in mice.

Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy.

Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists.

Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice

Directed evolution of novel adeno-associated viruses for therapeutic gene delivery.

Adeno-associated virus-mediated gene transfer

RETRACTED: Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy

P304

292-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CJI.0000000000000093

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brad E. Hoffman

George Aslanidi

Chen Ling

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26261893

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

4535186

http://www.w3.org/2001/XMLSchema#string

Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer

about

P2860

P2860

Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932